A clearer insight into this question is important in view of USP19 being a candidate gene for PD39 and as USP19 inhibitors have recently been described77 and might be a therapeutic approach for slowing the progression of PD or other misfolded protein associated neurodegenerative diseases. This evidence concerns the gene USP19 and neurodegenerative disease.